Date closed: 5/16/2016
Value: US$24.6 million
On May 16, 2016, Zenith Epigenetics Corp. announced that it closed a private placement of 24,560,500 common shares at a price of US$1.00 per share for gross proceeds of US$24,560,500 to Eastern Capital Limited. The shares are subject to a four month hold period.
Zenith Epigenetics Corp., headquartered in Calgary, Alberta is a biotechnology firm.
BLG represented Zenith Epigenetics Corp. by Lloyd McLellan.